000 01284 a2200337 4500
005 20250516153147.0
264 0 _c20140311
008 201403s 0 0 eng d
022 _a2210-3244
024 7 _a10.1016/j.gpb.2013.04.003
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSt-Coeur, Patrick-Denis
245 0 0 _aLeveraging metabolomics to assess the next generation of temozolomide-based therapeutic approaches for glioblastomas.
_h[electronic resource]
260 _bGenomics, proteomics & bioinformatics
_cAug 2013
300 _a199-206 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650 0 4 _aAnimals
650 0 4 _aAntineoplastic Agents, Alkylating
_xtherapeutic use
650 0 4 _aDacarbazine
_xanalogs & derivatives
650 0 4 _aDrug Resistance, Neoplasm
650 0 4 _aGlioblastoma
_xdrug therapy
650 0 4 _aHumans
650 0 4 _aMetabolomics
_xmethods
650 0 4 _aPrognosis
650 0 4 _aTemozolomide
700 1 _aTouaibia, Mohamed
700 1 _aCuperlovic-Culf, Miroslava
700 1 _aMorin, Pier
773 0 _tGenomics, proteomics & bioinformatics
_gvol. 11
_gno. 4
_gp. 199-206
856 4 0 _uhttps://doi.org/10.1016/j.gpb.2013.04.003
_zAvailable from publisher's website
999 _c22804350
_d22804350